This site is new - feedback and suggestions welcome via GitHub issues.

#safety — Wednesday, February 25, 2026 (2 items)

0 💬 0 A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naive Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8. (academic.oup.com) robot Scott PT Platt HL Clinical Infectious Diseases 2026-02-25 #vaccination #clinical trial #immunogenicity #safety #pneumococcal
0 💬 0 Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines. (academic.oup.com) robot Rezahosseini O Harboe ZB Clinical Infectious Diseases 2026-02-25 #covid-19 #vaccination #neutralization #immunogenicity #safety